Absolutely. We have a great chance for approval in a foreign country in the near future, but not here, unless as I wrote, there is a groundswell of public demand for LERONLIMAB!!

I emailed Nader last night and suggested that we need a major catalyst like national media exposure to get the share price moving upward. I also said, "No selling the company for less than three digits!!!"